Julius Strauss
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 62
- Cancer Immunotherapy and Biomarkers 51
- Colorectal Cancer Treatments and Studies 11
- CAR-T cell therapy research 7
- Immunology 28
- Immunotherapy and Immune Responses 24
- Co-authors
- James L. GulleyJeffrey SchlomRenee N. DonahueRavi A. MadanJennifer L. MartéChristopher R. HeeryClaudia PalenaCaroline Jochéms
- Journals
- Journal of Clinical Oncology (25 papers)Journal for ImmunoTherapy of Cancer (8 papers)Annals of Oncology (7 papers)The Oncologist (7 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Julius Strauss
75 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 1.2k
- Immunology 722
- Biotechnology 81
- Pulmonary and Respiratory Medicine 288
- Cancer Research 127
Countries citing papers authored by Julius Strauss
This map shows the geographic impact of Julius Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julius Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julius Strauss more than expected).
Fields of papers citing papers by Julius Strauss
This network shows the impact of papers produced by Julius Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julius Strauss. The network helps show where Julius Strauss may publish in the future.
Co-authors
The 25 scholars most cited alongside Julius Strauss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 10 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 30 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 13 | |
| 9 | 2021 | 43 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 5 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 6 | |
| 14 | 2019 | 45 | |
| 15 | 2019 | 8 | |
| 16 | 2018 | 116 | |
| 17 | Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors Hit paper breakdown → | 2018 | 327 |
| 18 | 2015 | 8 | |
| 19 | 2015 | 1 | |
| 20 | 2014 | 14 |
About Julius Strauss
Julius Strauss is a scholar working on Oncology, Immunology, Biotechnology, Pulmonary and Respiratory Medicine and Dermatology, having authored 81 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (51 papers), Immunotherapy and Immune Responses (24 papers), Prostate Cancer Treatment and Research (16 papers), Cancer Research and Treatments (11 papers), Colorectal Cancer Treatments and Studies (11 papers), Virus-based gene therapy research (8 papers), Colorectal and Anal Carcinomas (7 papers) and CAR-T cell therapy research (7 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (722 citations), Biotechnology (81 citations), Pulmonary and Respiratory Medicine (288 citations) and Cancer Research (127 citations). Julius Strauss has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include James L. Gulley, Jeffrey Schlom, Renee N. Donahue, Ravi A. Madan, Jennifer L. Marté, Christopher R. Heery, Claudia Palena, Caroline Jochéms, Lisa M. Cordes and Marijo Bilušić. Their work appears in journals such as Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Annals of Oncology, The Oncologist and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.